Jump to content

Is surgical resection indicated for a solitary non–small

Recommended Posts

cell lung cancer recurrence?

http://jtcs.ctsnetjournals.org/cgi/cont ... /131/4/838

Tomoyuki Hishida, MD a , * , Kanji Nagai, MD a , Junji Yoshida, MD a , Mitsuyo Nishimura, MD a , Gen-ichiro Ishii, MD b , Motoki Iwasaki, MD c , Yutaka Nishiwaki, MD a

a Department of Thoracic Oncology, National Cancer Center Hospital East, Chiba, Japan

b Pathology Division, National Cancer Center Research Institute East, Chiba, Japan

c Epidemiology and Prevention Division, Research Center for Cancer Prevention and Screening, National Cancer Center, Tokyo, Japan

Received for publication September 8, 2005; revisions received November 20, 2005; accepted for publication November 28, 2005.

* Address for reprints: Tomoyuki Hishida, MD, Department of Thoracic Oncology, National Cancer Center Hospital East, 6-5-1, Kashiwanoha, Kashiwa, Chiba, 277-8577 Japan (Email: thishida@nifty.com).

OBJECTIVES: Some investigators have reported long-term survival after surgical resection of a solitary non–small cell lung cancer recurrence in various sites. However, the role and indications of the second operation remain unclear.

METHODS: We reviewed 28 patients with a solitary recurrence after successful initial resection of primary non–small cell lung cancer who underwent resection of the recurrent lesion. The clinicopathologic factors associated with outcome were analyzed.

RESULTS: There were 17 men and 11 women. Recurrence resection was performed for the following sites: 16 in the lung, 5 in the brain, 2 in the adrenal gland, and 1 each in the chest wall, stomach, skin, pelvic lymph node, and malar bone. The median survival time was 25 months, and the 1-, 2-, and 5-year survival rates after recurrence were 89%, 59%, and 32%, respectively. Advanced p-stage (p-stage II and III, n = 14) of the primary tumor was the significant negative prognostic factor. Patients with p-stage II or III had survival equivalent to that of those who had multiple recurrences or were unfit for further surgical intervention.

CONCLUSIONS: Resection of a solitary non–small cell lung cancer recurrence might provide long-term survival in highly selected patients. However, surgical resection might be contraindicated if the primary tumor is stage II or III.

Abbreviations and Acronyms FDG = 18F fluorodeoxyglucose; NSCLC = non–small cell lung cancer; PET = positron emission tomography; RFI = recurrence-free interval

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Reply to this topic...

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Create New...

Important Information

By using this site, you agree to our Terms of Use.